-- D-Pharm Climbs Most in Two Weeks on Deal to Acquire Thrombotech
-- B y   D a v i d   W a i n e r
-- 2012-05-07T12:28:01Z
-- http://www.bloomberg.com/news/2012-05-07/d-pharm-climbs-most-in-two-weeks-on-deal-to-acquire-thrombotech.html
D-Pharm Ltd. (DPRM)  rose the most in more
than two weeks after the biopharmaceutical company reached an
initial agreement to buy Thrombotech Ltd., which is developing a
peptide that improves the efficiency of stroke medication.  The shares  of the Nes Ziona, Israel-based company rose 8
percent, the biggest intraday advance since April 19, to 1.011
shekels at 3:11 p.m. in  Tel Aviv .  To contact the reporter on this story:
David Wainer in Tel Aviv at 
 dwainer3@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  